8 Results (Page 1 of 1)
Australia Free Markets Research Reports
Australia Home Healthcare Market Analysis Sample Report
Australia home healthcare market is projected to grow from $4.35 Bn in 2022 to $8.94 Bn in 2030 with a CAGR of 9.43% for the year 2022-2030. The market has witnessed significant growth post-pandemic. The market is segmented by product, service, software, and by region.
Australia Lung Cancer Drugs Market Analysis Sample Report
Lung cancer is the fifth most common type of cancer affecting the Australian population, therefore the Australia lung cancer drugs market is projected to grow during the forecast period. The market is segmented by type, treatment, end user, route of administration, and distribution channel.
Australia OTC Drugs Market Analysis Sample Report
Australia Over The Counter (OTC) drugs market is projected to grow from $2.04 Bn in 2022 to $3.95 Bn in 2030 with a CAGR of 8.6% for the year 2022-2030. Major OTC innovation trends include treatment based, lifestyle based, format based and extended offering. The market is segmented by drug type and by distribution channel.
Australia Primary Hyperoxaluria (PH) Market Analysis Sample Report
Australia Primary Hyperoxaluria (PH) market stood at around $2.1 Mn in 2022 and is projected to reach $8.8 Mn with a CAGR of 19% for the year 2022-2030. The market is segmented by type, diagnosis, drug, treatment and by distribution channel. Alnylam Pharmaceuticals and Dicerna Pharmaceuticals are some of the key players in the Australia PH market.
Australia Sickle Cell Disease Market Analysis Sample Report
Australia Sickle Cell Disease market is expected to grow from $1.1 Mn in 2022 to $2.6 Mn in 2030 with a CAGR of 11% for the year 2022 to 2030. The market is segmented by treatment modality and by distribution channel. Novartis and AstraZeneca are some of the key players in the Australia sickle cell disease market.
Australia Physiotherapy Market Analysis Sample Report
The Australia physiotherapy market is expected to witness growth from $638 Mn in 2022 to $1,126 Mn in 2030 with a CAGR of 7.35% for the year 2022-2030. Arthritis, osteoporosis and back pain are the major conditions that require physiotherapy. The market is segmented by treatments and conditions.
Australia Patient Support Program Market Analysis Sample Report
Patient Support Programs (PSP) in Australia provide patients with significant value through the accessibility of information and support during and after the course of their treatment, therefore, leading to the growth of Australia patient support programs. Pharmaceutical companies sponsored PSPs are designed to aid compliance and lifestyle choices.
Australia Alzheimer's Disease Market Analysis Sample Report
The growing prevalence of Alzheimer's disease in elderly women in Australia is responsible for the growth of Australia Alzheimer's disease market. The market is segmented by product, drug, and distribution channel. Roche, Eisai, and Novartis are some of the key competitors in the market.